Off label drugs and pediatric hematology-oncology practices;Médicaments hors autorisation de mise sur le marché en hématologie-oncologie pédiatrique

Archives de Pediatrie

Volumn 13, Issue 9, 2006, Pages 1267-1268

  Le Guyader, N ^a   Pouliquen, A L ^a   Benoit, G ^a   Leverger, G ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Antineoplastic agents; Child; Drug approval

Indexed keywords

CHLORPROMAZINE; CISPLATIN; PIPERACILLIN PLUS TAZOBACTAM;

CHILD HOSPITALIZATION; CHILDHOOD CANCER; CLINICAL PROTOCOL; DRUG UTILIZATION; FEBRILE NEUTROPENIA; HEMATOLOGIC DISEASE; HUMAN; LETTER; LYMPHOMA; NEUROBLASTOMA; OFF LABEL DRUG USE; OSTEOSARCOMA; PRESCHOOL CHILD; PRESCRIPTION; SOLID TUMOR; TREATMENT INDICATION;

ANTINEOPLASTIC AGENTS; CHILD; DRUG APPROVAL; DRUG UTILIZATION; HUMANS; NEOPLASMS; PROSPECTIVE STUDIES;

EID: 33748323131     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2006.05.011     Document Type: Letter

References (5)

1. Treluyer J.M., and Pons G. Quoi de neuf en pharmacologie pédiatrique ?. Arch. Pediatr. 7 (2000) 1330-1338
2. Autret-Leca E., Bensouda-Grimaldi L., Le Guellec C., et al. L'enfant et les médicaments : application à la prescription en pédiatrie. Arch. Pediatr. 13 (2006) 181-185
3. Le Guyader N., Auvrignon A., Vu-Thien H., et al. Piperacillin-tazobactam and netilmicin as a safe and efficacious empirical treatment of febrile neutropenic children. Support. Care Cancer 12 (2004) 720-724
4. Conroy S., Newman C., and Gudka S. Unlicensed and off label drug use in acute lymphoblastic leukaemia and other malignancies in children. Ann. Oncol. 14 (2003) 42-47
5. ® dans la prise en charge des enfants neutropéniques fébriles. Pathol. Biol. 52 (2004) 550-555